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1. Abstract 
“The association between neuropeptide levels, lifestyle and BMI in postpartum women  
– a follow-up study” 
Author: Ameli Ingemansson. 
Supervisor: Ulrika Andersson Hall. Co-supervisor: Agneta Holmäng 
Degree project, Programme in Medicine  
Department of physiology. University of Gothenburg, Sweden, 2016. 
Background: Women with a pre-pregnancy BMI >25 kg/m² both have a higher risk of 
pregnancy-related complications such as gestational diabetes, as well as of remaining 
overweight post-partum, which is a well-known risk factor for many welfare-diseases. Among 
other factors, lifestyle changes and neuropeptide levels may influence BMI development 
during pregnancy and post-partum. 
Aim: To follow up women 3 – 5 year post-partum and to measure their levels of 
neuropeptides (leptin, insulin and Agouti-related peptide (AgRP)) in cerebrospinal fluid 
(CSF) and serum (s), and to study if BMI changes (pre- and post-partum) and fat mass (post-
partum) were related to neuropeptide levels and insulin sensitivity. Lifestyle characteristics 
such as diet and physical activity were also studied. 
Methods: Women (n=25) were recruited from a previous pregnancy study conducted in 2010 
– 2013. Blood and CSF samples were collected at caesarean and post-partum, body 
composition were determined, and questionnaires regarding dietary intake, physical activity 
was distributed. The women were divided into three groups based on their BMI changes from 
pre-pregnancy to follow-up visits: Loss, Stable and Gain. 
Results: The lowest BMI was found in the Stable group (BMI 26.2 ± 4.5 kg/m2 at follow up), 
where also s-AgRP levels remained higher post-partum compared with the other groups. The 
BMI Gain group (BMI 31.7 ± 3.1 kg/m2 at follow up) had the lowest CSF/S leptin quota, 
highest increase in CSF insulin levels and were also found to have the highest insulin 
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resistance at follow up (HOMA-IR = 2.4 ± 0.8). Additionally, BMI correlated to changes in s-
AgRP levels post-partum (ρ = -0.511) and to CSF/S leptin (ρ = -0.672). Regarding lifestyle, 
fat intake correlated (ρ = 0.576) to the increment of CSF AgRP after pregnancy, and physical 
activity correlated (ρ = -0.507) to lower fat mass. 
Conclusions: High s-AgRP levels and a high CSF/S leptin quota, in addition to physical 
activity might predict lower BMI after pregnancy. Evidence of correlation between fat intake 
and CSF AgRP levels was found for the first time and would be of interest to study further. 
Key-words: Agouti-related peptide, weight-loss, pregnancy, lifestyle, BMI. 
2. Introduction 
The rising proportion of overweight individuals in our population is a major concern. In 
Sweden, as many as 38.5% of women are overweight (Body Mass Index >25 kg/m2) or even 
obese (BMI >30 kg/m2) at the start of pregnancy (1). The BMI of pregnant women positively 
correlates with increased risk of maternal and fetal complications (2), where gestational 
diabetes mellitus is one of the most common health problems (3). Women with gestational 
diabetes have a higher risk for developing type II diabetes later in life (4). Pre pregnancy BMI 
together with excessive gestational weight gain during pregnancy does not only predict short-
term morbidity and higher weight retention after pregnancy, but also potential lifelong obesity 
(5). Gestational weight gain alone explains half of the post-partum weight retention (6), and is 
therefore the greatest independent predictor (7). 
During pregnancy the energy intake increases and thermogenesis is supressed (8, 9), to 
achieve a favourable condition for foetal development and lactation. This change in energy 
balance is believed to partly depend on the orexigenic Agouti-related Peptide (AgRP) and the 
anorexigenic neuropeptides leptin and insulin, and their interactions within the brain.  
5 
 
Concurrently with fat-mass gain and placental growth during pregnancy, serum (S) and 
cerebrospinal fluid (CSF) levels of leptin are increased (10, 11). They are both strongly 
correlated with BMI and body fat during pregnancy (12). Even though obese and overweight 
women have higher levels of CSF leptin, there is a negative correlation between the quota 
CSF/S and increasing BMI, due to a saturable transport of leptin to the brain at the blood-
brain barrier (BBB) (13). The contradictory increase in appetite, despite an elevation of this 
anorexigenic peptide in pregnant women in general, and obese pregnant women in particular 
(14, 15), points to a central resistance to leptin with increasing central concentrations.  
As neuropeptides also interact and regulate each other’s secretion, the suppressive effects that 
leptin exerts on AgRP (16, 17) may be reversed by leptin resistance (18), which is believed to 
eventually initialize a compensatory increase in CSF AgRP (19-21). Thus, increased food 
intake in pregnant women can be seen as a consequence of higher central concentrations of 
AgRP along with weight gain and foetal and placental growth, which might be necessary to 
counteract the inhibitory effects of leptin at the brain (22). This would further explain how 
obese women are able to keep a positive energy balance. 
The theory of relative resistance due to saturable transport over the BBB is also applicable to 
insulin (23). Insulin regulates appetite in a faster manner than leptin, as it is secreted as a 
direct response to food intake, compared to the continuous release of leptin from adipose 
tissue. Peripheral insulin resistance develops during pregnancy and serum insulin levels are 
elevated to ensure normal glucose metabolism and adequate nutrition of the foetus. There is 
an inverse correlation between insulin sensitivity and fat-mass gained in normal weight 
pregnant women, and this correlation seems to be even more accentuated along with 
pregnancy, and in obese women (24). The decreased sensitivity to insulin late in pregnancy is 
believed to be caused by corticosteroids and placental hormones (25). In most cases, insulin 
sensitivity will return to normal shortly after delivery as the placenta is removed. 
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Results from an earlier study from our lab showed for the first time that AgRP was produced 
in the human placenta, and that s-AgRP levels were elevated in pregnancy (19). This study 
also showed that all three of the neuropeptides AgRP, insulin and leptin in CSF were higher in 
obese and overweight women than in normal-weight women during pregnancy. Accordingly, 
insulin and leptin levels in serum were higher in obese women compared to normal weight 
women, but their quota in CSF/S was lower. Serum (S)-AgRP, however, was higher in serum 
in normal weight women. The conclusions drawn from this study were that elevated levels of 
CSF AgRP throughout pregnancy protected women from the suppressive effects of leptin and 
insulin on appetite, and that high CSF AgRP promoted a positive energy balance in 
overweight and obese pregnant women. It was also suggested that high s-AgRP levels were 
coupled with lower BMI and a favourable metabolic profile. These findings support the 
theory of resistance at the level of the brain for leptin, and suggest that central AgRP interacts 
with the effects of leptin to meet the metabolic requirements of pregnancy. However, the 
actions of AgRP on energy balance are still poorly understood, especially during times of 
weight gain or weight loss, such as during and after pregnancy. A follow up study was 
therefore initiated to study how the neuropeptides develop along with BMI changes after 
pregnancy. 
The different determinants for weight development after pregnancy are, of course, not only 
neuropeptides. For example, it has been shown that physical activity (PA) has many beneficial 
effects after pregnancy, including physical and mental health and also impacts on weight loss 
(26). If weight loss is a desirable objective PA should be combined with diet 
recommendations and reduced energy intake (27). Thus, these parameters are also of interest 
when studying factors connected to weight changes. 
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3. Aim 
The purpose of this study was to follow up women whose neuropeptide levels in the CSF and 
serum were measured during pregnancy in a study carried out 3 – 5 years earlier (19) to find 
out how their weights developed after pregnancy, and if weight differences relate to changes 
in neuropeptide levels, and metabolic health. As diet and PA are believed to play major roles 
in postpartum weight loss (28), we analyzed PA and food intake. With more knowledge about 
changes of these parameters, we might find clues to who will normalize their weight, and 
predict the risk of developing or remaining overweight or obese after pregnancy.  
4. Material and methods 
4.1 Subjects 
All 74 women from the earlier study (19) were contacted by phone, and 25 women agreed to 
participate in this follow-up.  
Inclusion criteria in the first study were uncomplicated pregnancies and healthy subjects, 
screened by medical history. They were all planned for caesarean section and CSF samples 
were extracted before the lumbar anaesthesia to minimize the numbers of lumbar puncion. All 
subjects were normoglycemic, non-smokers, and did not have a risk consumption of alcohol 
at the entry of the study. Dieting and use of weight-loss supplements within 6 months before 
pregnancy were excluding factors, and no dietary recommendations were given to the women 
in the study. Exclusion criteria for the present study were pregnancy during the last 12 months 
or history of diabetes, neurological, hepatic-, renal- or major psychiatric disease. Four of the 
participants had been pregnant during the time period between these two studies, and the 
average time of follow up was 5 years after their latest pregnancy. 
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4.2 Anthropometry and body composition 
Body composition of the participants was determined by a whole-body GE Lunar iDXA 
(Dual-energy x-ray absorptiometry) scan, where fat mass (%) of total body mass was 
calculated by making transverse scans from head to toe (29). All participants wore light-
weight clothes and had their metal jewellery removed. Also android and gynoid distributed fat 
mass were analysed via Prodigy enCORE software (30). Android fat mass is fat distributed 
around the abdomen between the ribs and the pelvis, and gynoid fat is the fat distributed 
around the hips and upper thighs (For visualization see Appendix1). Both were computed in 
percent of total mass of the area. 
4.3 Blood and CSF sampling 
After an overnight fast, venous blood and CSF samples were collected. Before spinal 
anaesthesia lumbar punction was used to extract 12 ml of CSF, and together with blood 
samples directly transported to the Laboratory for Clinical Chemistry and the Neurochemistry 
Department and Diagnostics Research Unit at the Sahlgrenska University Hospital in 
Mölndal.  
4.4 Hormone assays 
Leptin and AgRP in CSF and serum were analysed by enzyme-linked immunosorbent assay 
(R&D systems) at the Neurochemistry Department and Research Unit. CSF insulin was 
analysed with a double antibody radioimmunoassay (Linco Research, St Charles, MO, USA) 
at the Department of Clinical Science, Lund University. All other biochemical analyses were 
performed by the accredited clinical chemistry lab (SWEDAC ISO 15189). Due to technical 
difficulties or subjects declination, CSF was only sampled from 17 of the 25 women. 
4.5 Questionnaires regarding lifestyle 
The participants reported their dietary intake during the three previous months by completing 
a food frequency questionnaire. This questionnaire has been validated in the large SOS 
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(Swedish Obese Subjects) study at Sahlgrenska Academy (31). The participants also 
completed a short questionnaire regarding PA at work and during spare time where they 
ranked their levels of activity on a scale from 0/1 – 4 (see Appendix 3). Insulin resistance was 
estimated by HOMA-IR (Homeostatic Model Assessment – Insulin Resistance) which is a 
highly sensitive and specific method to assess insulin resistance (32). 
All the personal information regarding the participants was transcoded so that no results could 
be backtracked. 
5. Statistical methods 
The clinical data and the questionnaire results were collected and entered in Excel databases. 
Statistical analyses were performed using SPSS.  
In the earlier study women were divided into groups based on their BMI before pregnancy; 
normal weight (NW) with BMI 18.5 – 25 kg/m2, overweight (OW) with BMI >25 kg/m2, and 
obese (OB) with BMI >30 kg/m2. The women in our study were divided into three groups 
based on changes in BMI from before pregnancy to after, with a total range of BMI changes 
from -3.2 – 6.7 kg/m2. The three groups were divided into quartiles, with a midfield 
consistent of the second and third quartile. Hence, the 1:st quartile (<-0.6) = BMI Loss, the 
2:nd and 3:rd quartile (-0.4 – 2.1) = BMI Stable, and the 4:th quartile (>2.6) = BMI Gain.  
The groups were compared for significant differences by medians (because of small sample 
sizes) using the Kruskal Wallis test, which is a non-parametric analysis of variance that does 
not assume normal distributed populations. The Whitney U method, with a significance level 
of <0.05 was used as Post-Hoc test. Because of outliers particularly in serum and CSF-
analyses, relations were evaluated by calculation of Spearman’s correlation coefficient (ρ). 
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Even though there were clinical data that deviated >2 SD from the mean, no data were 
excluded during the analyses. This was because of the restricted numbers of participants, and 
uncertainty if deviations were due to interpersonal differences or analysing errors. 
6. Ethics 
This project was undertaken at the Sahlgrenska hospital and was approved by the ethical 
committee at the University of Gothenburg (dnr 402-08 and dnr 750-15) as a part of the 
PONCH study. Women from the earlier study (19) were contacted and asked to participate, 
with information verbally and written. Informed consent was obtained from all participants. 
7. Results 
7.1 Body composition and background characteristics 
7.1.1 Background characteristics 
In the earlier study on neuropeptides at caesarean, women were divided into groups based on 
their pre-pregnancy BMI (Body Mass Index); Normal Weight (NW), Over Weight (OW), and 
Obese (OB). In the current study, these women were divided into quartiles based on their BMI 
development from pre-pregnancy to follow up, with the two quartiles in the middle equalling 
the Stable group. Since the previous study, most women of NW were distributed into the 
Stable group. OW mostly into Stable and Gain groups, and OB into Loss and Stable groups 
(Figure 1).  
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Background characteristics in groups based on BMI development are displayed in Table 1 (for 
background characteristics based on previous groups, see Appendix 2).  
The BMI at follow up was significantly different between the groups, with the Stable group 
having the lowest BMI.  During pregnancy there was no difference in insulin resistance, as 
measured by the Homeostatic Model Assessment – of Insulin Resistance (HOMA-IR) 
whereas at follow up the Gain group had higher insulin resistance than the Stable group. No 
significant differences were found between the groups regarding P-glucose, neither during 
pregnancy, nor at the follow up (results not shown) and time since last pregnancy. 
Table 1. BMI and background characteristics in groups based on BMI development. 
 
BMI Loss 
(n) 
BMI Stable 
(n) 
BMI Gain 
(n) 
P 
Pre-pregnancy BMI (kg/m2) 
29.6 (21.8 – 34.0) 
(6) 
26.2 (18.0 – 33.3) 
(13) 
27.7 (23.3  32.4) 
(6) 
0.345 
a. 0.174 
b. 0.631 
c. 0.380 
Gestational weight gain (kg) 
11.0 (7.1 – 18.0) 
(6) 
12.0 (-2.0 – 17.0) 
(13) 
16.0 (10.0 – 27.0) 
(6) 
0.100 
a. 0.628 
b. 0.077 
c. 0.053 
BMI at follow up (kg/m2) 
27.0 (20.2 – 31.5) 
(6) 
26.2 (18.4 – 33.7) 
(13) 
31.7 (27.6 – 37.0) 
(6) 
0.024 
a. 0.930 
b. 0.016 
c. 0.014 
Weight change post-partum 
(kg) 
-6.2 (-8.8 – -1.8) 
(6) 
1.1 (-1.1 – 5.6) 
(13) 
12.9 (7.1 – 17.3) 
(6) 
<0.001 
a. 0.001 
b. 0.004 
c. 0.001 
BMI change from pre-
pregnancy to follow up (kg/m2) 
-2.2 (-3.2 – -0.7) 
(6) 
0.4 (-0.4 – 2.1) 
(13) 
4.5 (2.7 – 6.7) 
(6) 
<0.001 
a. 0.001 
b. 0.004 
c. <0.001 
Age (years) 
42.1 (36.7 – 45.0) 
(6) 
40.9 (27.4 – 46.7) 
(13) 
36.9 (29.6 – 42.6) 
(6) 
0.163 
a. 0.292 
b. 0.055 
c. 0.237 
Parity (n) 
3 (2 – 3) 
(6) 
2 (1 – 3) 
(13) 
2 (1 – 2) 
(6) 
0.035 
a. 0.070 
b. 0.018 
c. 0.212 
Time since last pregnancy 
(years) 
6 (4 – 6) 
(6) 
4 (2 – 6) 
(13) 
6 (4 – 6) 
(6) 
0.468 
a. 0.930 
b. 1.000 
c. 0.329 
HOMA-IR during pregnancy 
1.1 (0.3 – 4.6) 
(6) 
1.2 (0.1 – 3.4) 
(13) 
1.1 (0.4 – 1.7) 
(6) 
0.866 
a. 0.329 
b. 0.873 
c. 0.539 
HOMA-IR at follow up 1.0 (0.8 – 2.8) 
(5) 
1.1 (0.4 – 2.3) 
(13) 
2.4 (0.7 – 2.8) 
(6) 
0.080 
 a. 0.522 
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Parity was significantly higher in the Loss group, with a median of one more child than the 
other groups. Additionally, we found negative correlations between parity and HOMA-IR, S-
leptin, weight change and BMI at follow up. Though these correlations were weak (data not 
shown), they all pointed in the same direction, with parity in this study being correlated with 
weight loss and the positive metabolic changes that followed. 
7.1.2 BMI development 
All groups 
increased their 
weight during 
pregnancy and 
decreased it at 
follow up (Figure 
2). BMI after 
pregnancy was 
significantly 
different between 
the groups, with Stable group having the lowest BMI generally. Weight changes significantly 
differed between the three groups in order Loss – Stable – Gain, and the Loss group not only 
tended to gain less weight during pregnancy, they also lost significantly more after pregnancy 
(Table 1).  
b. 0.273 
c. 0.023 
Values are medians, with minimum and maximum values within parenthesis. P-values based on 
Kruskall Wallis. Significance at the <0.05 level. 
a. Whitney U comparison between Loss – Stable 
b. Whitney U comparison between Loss – Gain  
c. Whitney U comparison between Stable – Gain 
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In Table 2 it is shown that BMI at follow up correlated strongly and significantly to serum (s) 
-leptin, and weaker but significantly to Cerebrospinal Fluid (CSF) leptin. Furthermore it 
correlated negatively to the ratio CSF/S leptin at follow up, suggesting increased leptin 
transportation to the brain with loss in BMI. Additionally, weight loss after pregnancy 
correlated significantly to the change in HOMA-IR which suggests that insulin resistance was 
reduced by weight loss. BMI at follow up further correlated negatively to the change in s-
AgRP levels which may indicate elevated levels of orexigenic s-AgRP among women with 
lower BMI after pregnancy. 
 
7.1.3 Body composition 
Not surprisingly, fat mass was found to be lower in the BMI Stable group (Table 3) with a 
tendency of android fat distributed the same between the groups, but gynoid not. 
Table 2. Spearman correlations (ρ) to post-partum weight loss and BMI at follow up. 
  
CSF leptin 
at follow 
up 
S-leptin 
at follow 
up 
CSF/S 
leptin at 
follow up 
S-AgRP 
change post-
partum 
HOMA-IR 
at follow 
up 
HOMA-IR 
change post-
partum 
BMI at 
follow up 
ρ 0.571 0.729 -0.672 -0.511 0.500 0.455 
p 0.017 0.000 0.003 0.021 0.013 0.022 
n 17 25 17 20 24 25 
Weight loss 
post-
partum 
ρ 0.216 0.439 -0.459 -0.373 0.373 0.429 
p 0.405 0.028 0.064 0.105 0.073 0.033 
n 17 25 17 20 24 25 
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Fat mass % positively correlated with s-leptin, CSF leptin, and HOMA-IR at the follow up, 
which was expected as central and peripheral leptin, as well as insulin resistance, tend to 
increase with body fat (Table 4.). Furthermore there was negative correlations to CSF/S 
leptin, s-AgRP and the change of s-AgRP after pregnancy, in accordance with the correlations 
to BMI values mentioned previously. S-insulin at follow up had a stronger positive correlation 
to fat with android than gynoid distribution. 
 
Table 3. Body composition at follow up. 
 
BMI Loss 
(n) 
BMI Stable 
(n) 
BMI Gain 
(n) 
P 
Fat mass (%) 38.5 (29.6 – 45.9) 
(6) 
38.0 (23.3 – 45.5) 
(13) 
43.5 (39.8 – 48.2) 
(6) 
0.077 
a. 0.792 
b. 0.055 
c. 0.039 
Android fat (%) 45.9 (25.8 – 47.1) 
(6) 
38.6 (17.8 – 53.1) 
(13) 
50.6 (44.2 – 55.1) 
(6) 
0.039 
a. 0.861 
b. 0.025 
c. 0.023 
Gynoid fat (%) 39.6 (36.1 – 50.6) 
(6) 
43.2 (27.7 – 48.9) 
(13) 
46.3 (41.9 – 50.7) 
(6) 
0.096 
a. 0.930 
b. 0.078 
c. 0.044 
Values are medians, with minimum and maximum values within parenthesis. P-
values based on Kruskall Wallis. Significance at the <0.05 level. 
a. Whitney U comparison between Loss – Stable 
b. Whitney U comparison between Loss – Gain  
c. Whitney U comparison between Stable – Gain 
Table 4. Spearman correlations (ρ) to body composition at follow up. 
  
S-insulin at 
follow up 
CSF leptin 
at follow up 
S-leptin at 
follow up 
CSF/S leptin 
at follow up 
S-AgRP at 
follow up 
S-AgRP change 
post-partum 
HOMA-IR 
at follow up 
Fat mass 
by DXA 
(%) 
ρ 0.527 0.498 0.832 -0.790 -0.445 -0.539 0.535 
p 0.007 0.042 0.000 0.000 0.026 0.014 0.007 
n 25 17 25 17 25 20 24 
Android 
fat (%) 
ρ 0.616 0.534 0.758 -0.776 -0.361 -0.510 0.520 
p 0.001 0.027 0.000 0.000 0.076 0.022 0.009 
n 25 17 25 17 25 20 24 
Gynoid 
fat (%) 
ρ 0.423 0.522 0.833 -0.685 -0.325 -0.522 0.410 
p 0.035 0.032 0.000 0.002 0.113 0.018 0.047 
n 25 17 25 17 25 20 24 
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7.2 Neuropeptides 
7.2.1 Agouti-related peptide (AgRP)  
We found an 
interesting 
narrowed span of 
s-AgRP levels at 
follow up (Figure 
3). The Stable 
group were the 
only group that 
remained at high 
s-AgRP levels 
after pregnancy, while the other two decreased (Table 5).  
 
 
Table 5. S-AgRP at follow up (FU) and the difference from pregnancy (Δ). 
 BMI Loss 
(n) 
BMI Stable 
(n) 
BMI Gain 
(n) 
P 
 
 
S-AgRP  
(pg/ml) 
 
 
 
 
CSF AgRP 
(pg/ml) 
FU 
16 (16 – 31) 
(6) 
25 (16 – 33) 
(13) 
20 (16 – 23) 
(6) 
0,471 
a. 0.373 
b. 0.624 
c. 0.285 
Δ 
-21 (-27 – 10) 
(5) 
1 (-45 – 22) 
(9) 
-24 (-42 – 18) 
(6) 
0,035 
a. 0.205 
b. 0.201 
c. 0.013 
FU 
34 (19 – 47) 
(4) 
41 (30 – 63) 
(19) 
38 (35 – 39) 
(3) 
0,432 
a. 0.287 
b. 0.593 
c. 0.351 
Δ 
8 (4 – 20) 
(4) 
25 (11 – 43) 
(8) 
12 (-20 – 27) 
(3) 
0,092 
a. 0.026 
b. 0.724 
c. 0.306 
Values are medians, with minimum and maximum values within parenthesis. P-values 
based on Kruskall Wallis. Significance at the <0.05 level. 
a. Whitney U comparison between Loss – Stable 
b. Whitney U comparison between Loss – Gain  
c. Whitney U comparison between Stable – Gain 
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Nearly all women 
increased their 
CSF AgRP at 
follow up (Figure 
4). The Stable 
group tended to 
have a greater 
increase in CSF 
AgRP than the 
other groups 
(Table 5). Interestingly, changes in CSF AgRP correlated weakly but significantly to changes 
in fat intake post-partum (See diet correlations in Figure 8). It also negatively correlated to 
years from last pregnancy (r = -0.608, p = 0.016), in other words; the longer time elapsed 
since the last pregnancy, the more similar CSF AgRP levels were to those during pregnancy. 
7.2.1. Insulin 
Most of the 
participants had a 
small increment of 
their CSF insulin 
after pregnancy, as 
can be seen in 
Figure 5. Three 
participants 
decreased their 
CSF insulin and 
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they were all from the BMI Stable group. The two women who had the highest increase in 
CSF insulin were from the BMI Gain group, and this group also increased their CSF insulin 
significantly more than the other groups. No differences regarding serum insulin were found 
between the groups (results not shown). 
7.2.2 Leptin 
CSF/S leptin 
levels in the BMI 
Gain group was 
lower than the 
Stable group at 
follow up (Figure 
6 and Table 7). 
The saturable 
transport over the 
BBB developing 
during pregnancy did thus not in general seem to be reversed post-partum as many of the 
participants actually increased their CSF/S leptin quota post-partum. 
Table 6. CSF insulin at follow up (FU) and the difference from pregnancy (Δ). 
 BMI Loss 
(n) 
BMI Stable 
(n) 
BMI Gain 
(n) 
P 
CSF Insulin  
(uU/ml) 
FU 
0,22 (0,12 – 0,39) 
(4) 
0,06 (0,04 – 0,30) 
(7) 
0,52 (0,12 – 0,94) 
(3) 
0,179 
a. 0.296 
b. 0.372 
c. 0.086 
Δ 
0,04 (-0,04 – 0,10) 
(3) 
0,01 (-0,36 – 0,04) 
(5) 
0,19 (0,10 – 079) 
(3) 
0,036 
a. 0.180 
b. 0.077 
c. 0.025 
Values are medians, with minimum and maximum values within parenthesis. P-values 
based on Kruskall Wallis. Significance at the <0.05 level. 
a. Whitney U comparison between Loss – Stable 
b. Whitney U comparison between Loss – Gain  
c. Whitney U comparison between Stable – Gain 
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7.3 Lifestyle 
In Figure 7 it is 
shown that in the 
BMI Stable group 
we found that all 
of the participants 
except for one 
person decreased 
their energy 
intake. In the other 
groups the change in energy intake was more diverse. 
Table 7. Serum and CSF/S leptin at follow up (FU) and the difference from pregnancy (Δ). 
 BMI Loss 
(n) 
BMI Stable 
(n) 
BMI Gain 
(n) 
P 
 
 
CSF/S 
leptin 
FU 
0,017 (0008 – 0,025) 
(4) 
0,020 (0,010 – 0,031) 
(10) 
0,006 (0,006 – 0,14) 
(3) 
0,073 
a. 0.396 
b. 0.154 
c. 0.028 
Δ 
-0,008 (-0,013 – 0,009) 
(3) 
0,003 (-0,006 – 0,022) 
(8) 
-0,004 (-0,013 – 0,002) 
(3) 
0,240 
a. 0.153 
b. 0.827 
c. 0.221 
Values are medians, with minimum and maximum values within parenthesis. P-values based on 
Kruskall Wallis. Significance at the <0.05 level. 
a. Whitney U comparison between Loss – Stable 
b. Whitney U comparison between Loss – Gain  
c. Whitney U comparison between Stable – Gain 
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There were no 
significant 
differences 
regarding diet or 
physical activity 
(PA) between the 
groups (results 
not shown). 
Neither was 
there any correlation between BMI at follow up and diet. However, the change in CSF AgRP 
correlated significantly to changes in fat intake post-partum, with no correlation to any other 
macronutrient (Figure 8).  
 
 
There were significant negative correlations between PA at spare time and fat mass. However, 
android fat did not correlate, but gynoid fat did (Table 8). No significant differences were 
found between the groups (results not shown). 
Table 8. Spearman correlations (ρ) to physical activity at follow up.   
  
S-leptin at 
follow up 
S-leptin change 
post-partum 
Fat mass at 
follow up 
Gynoid fat 
at follow up 
Android fat 
at follow up 
Physical activity 
- leisure 
ρ -0.482 -0.462 -0.507 -0.547 -0.359 
p 0.015 0.023 0.010 0.005 0.078 
n 25 24 25 25 25 
Physical activity 
- total  
ρ -0.288 -0.393 -0.272 -0.397 -0.126 
p 0.162 0.058 0.188 0.050 0.547 
n 25 24 25 25 25 
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8. Discussion 
Our major findings were that the Stable group had the lowest BMI, and also remained at 
higher serum Agouti-related peptide (s-AgRP) levels post-partum than the other groups. The 
BMI Gain group increased their levels of insulin in CSF, and had higher peripheral insulin 
resistance, measured by HOMA-IR, at the follow up. Low BMI correlated to physical activity 
(PA), to the increment of s-AgRP, to lower insulin resistance, and to higher CSF/S leptin 
quota. Evidence of correlation between fat intake and levels of CSF AgRP was found for the 
first time in human.  
Characteristic for the women in the Gain group was that they retained more weight after 
pregnancy. Furthermore they decreased their levels of peripheral AgRP more than the other 
groups, and low s-AgRP levels are, as mentioned previously, suggested to be connected to 
higher BMI (19). They also increased their CSF insulin levels more than the other groups and 
had higher peripheral insulin resistance, measured by HOMA-IR at follow up.  
Women with decreased weight compared with before pregnancy tended to gain less weight 
during pregnancy, and lost significantly more after pregnancy compared to the other groups, 
which may depend on lifestyle changes such as more physical activity, since this correlated to 
fat mass after pregnancy.  
The weight-stable women in our study remained at higher s-AgRP after pregnancy. The 
overall reduction of s-AgRP levels at follow up may be due to the removal of the placenta, 
which during pregnancy contributes to the peripheral synthesis that makes s-AgRP levels 
higher and probably also to larger variability during this period. Other peripheral sources of 
AgRP synthesis are adrenal glands, kidneys, and lungs (33). AgRP is released diurnally from 
the hypothalamus along with fasting (34) and may be elevated in serum from the adrenal 
glands in response to exercise (35). The increase in CSF AgRP might be connected to PA and 
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low BMI together with higher levels of peripheral AgRP found in this study. Women that kept 
a stable BMI from before pregnancy had lower BMI, fat mass, insulin resistance and CSF 
insulin. The low and stable levels of s-AgRP further confirms earlier findings which suggests 
that lower BMI is connected to higher s-AgRP levels in serum (12, 18, 19).  
Findings of a correlation between changes in CSF AgRP and changes in fat intake are in 
accordance with studies on rodents. These studies showed that higher fat intake promotes 
leptin resistance (36) via an inflammatory process at the AgRP neurons in the hypothalamus 
(37, 38), with a subsequent increase in CSF AgRP due to the lowered potency of leptin’s 
suppressive effect on these neurons (21, 39). This implicates that fat intake could have an 
orexigenic effect through altered levels of CSF AgRP, which remains to be proven in humans. 
Wei W et al. further describe that mice fed a high fat diet, even for a short period, have 
elevated CSF AgRP levels, but do not develop leptin resistance (21). In other words, fat 
intake may have a greater impact on energy balance than previously believed, and as 
described by Milanski et al., even fat quality may impact on the inflammatory response at the 
AgRP neurons (40). This result is interesting and needs to be studied further, especially with a 
larger sample size included, and also with determining of fat quality in the diet.  
BMI and fat mass at follow up additionally correlated to parameters that have been concluded 
to be coupled to BMI in earlier studies, such as serum and CSF leptin, HOMA-IR and 
negatively to CSF/S leptin (19, 41, 42). The lower CSF/S leptin during pregnancy correlated 
to BMI, and was not in general reversed at follow up. Thus this satiety in transportation to the 
brain would rather be linked to BMI and fat mass per se. 
The negative correlation between parity and HOMA-IR at pregnancy and to HOMA-IR 
change after pregnancy indicates development of increased insulin resistance with each 
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pregnancy, but also a greater reversion post-partum, which are both well-known phenomena 
(43).  
One of the strengths of this study is the even distribution between normal weight, over weight 
and obese participants from the first study. Additionally we were able to look at a longitudinal 
prospective development of the same women’s BMI and neuropeptides, instead of comparing 
pregnant women to a non-pregnant group. Another advantage is that the time span since their 
last pregnancy was long enough that their weight and neuropeptide levels should have 
stabilized.  
A factor to take into consideration was that as the samples were extracted at different times 
for caesarean and follow up, the neuropeptides were not analysed at the same time in parallel. 
Hence, there could be systematic errors regarding especially the AgRP and leptin components 
of the results in thus study. S-insulin was measured by a certified clinical chemistry lab, 
which should give reproducible results. Both sets of CSF insulin samples were measured 
simultaneously, and plans to do the same for AgRP and leptin have been made although they 
were not possible to carry out within the scope of this project. However, looking both at 
absolute values and changes from one time-point to another reduces the impact of systematic 
errors. 
We should furthermore take into account that planned caesarean section is not randomly 
performed on pregnant women, but inclusion and exclusion criteria in this study should 
minimize the risk that our women should differ in terms of progression of the pregnancy. 
There is also difficulty to recruit women for this kind of study, since testing may give rise to 
pain, and there was also a small risk for transient health complications from CSF sampling 
(post-spinal headache). It is also quite time-consuming to fill in extensive questionnaires, so it 
is possible that women who chose to participate in the follow up study are more ambitious 
and caring about a healthy lifestyle than women in the general population. This suggests a 
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possibility of bias in the recruited group, and might lead to selection towards a specific social 
class and tends to exclude others.  
As these results are based on a small group of individuals, they are mostly indicators of what 
could be of interest for further studies. Special care should be taken when interpreting results 
on diet and physical activity since there could be difficulties in questionnaire reliability (31). 
Especially for diet there is a known phenomenon that self-reported diet tends not to be totally 
reliable, particularly not for obese subjects (44), and on basis of a small number of 
participants. Hence, no significant differences between the groups were found regarding PA 
and diet. Though we decided to only use the interpersonal results from the dietary 
questionnaire, so that at least the changes in diet would be rather reliable since these results 
are based on reports from the same person, only at different times. Also, using correlations in 
addition to group analysis allowed us to use the full material as one group with a bigger 
sample size. 
9. Conclusions 
For the first time, it was possible to show that CSF AgRP in humans was correlated to fat 
intake. Both fat intake and fat quality would be interesting to study further, as this study 
suggests that diet composition could contribute to increased levels of CSF AgRP, and hence 
energy-homeostasis. 
S-AgRP was higher in participants with lower BMI, and BMI correlated negatively to 
changes in s-AgRP which further confirms earlier findings. Women with lower BMI were 
also more weight stable than the other groups which has not been shown before. Thus, high 
levels of s-AgRP and CSF/S leptin after pregnancy, in addition to physical activity might 
predict who will keep a low and stable BMI. 
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It is difficult to interpret whether body composition and habits determine neuropeptide levels, 
or if the reverse case is true. More longitudinal studies would therefore be of interest. 
10. Populärvetenskaplig sammanfattning på Svenska 
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Övervikt och fetma är som bekant en av de farligaste riskfaktorerna för flertalet 
välfärdssjukdomar. Under graviditeten ökar risken för komplikationer hos både mor och barn 
om kvinnan är överviktig eller fet (har ett ”Body mass index” (BMI) över 25 kg/m²). 
Sjukdomar som graviditets-diabetes och blodproppar ökar med stigande BMI, och risken att 
förbli överviktig/fet ökar ju mer man lagt på sig under graviditeten. Vid en normal graviditet 
ökar kvinnan i vikt trots att koncentrationen av centralt verkande hungerdämpande hormoner 
som insulin och leptin ökar. Leptin frigörs av fettmassa och från moderkakan, varför dessa 
nivåer stiger under graviditeten och vid ökande BMI. Insulin ökar också med stigande BMI, 
men frigörs snarare vid måltider än kontinuerligt, såsom leptin. Dessa båda koncentrationer 
stiger således även hos överviktiga/feta kvinnor under graviditeten. Trots att nivåerna av dessa 
båda hormoner stiger i både serum och i centrala nervsystemet (CNS) under graviditeten och 
vid ökande BMI, så verkar det föreligga någon form av mättnad både för transporten till 
hjärnan men också en sorts resistens i hjärnan, ju högre nivåer man utvecklar. Det är på så sätt 
man förklarar hur överviktiga kvinnor under graviditeten ändå kan tillgodogöra sig energi och 
fettmassa på liknande sätt som normalviktiga dito, trots höga nivåer av dessa 
hungerdämpande hormoner. 
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I en tidigare studie från forskargruppen fastslog man bland annat att moderkakan inte bara 
producerar hungerdämpande hormoner utan även ett hormon som verkar hungerstimulerande i 
CNS (AgRP). Detta hormonen har dock en annan effekt i blodet än i hjärnan, och man 
kopplade samma höga nivåer av AgRP i blod med lågt BMI. Man föreslog också en 
kompensatorisk ökning av det hungerstimulerande AgRP i CNS som svar på höga nivåer av 
insulin och leptin, men ville följa upp dessa resultat för att få en mer mångfacetterad bild av 
kvinnornas hormonnivåer och BMI-utveckling efter genomgången graviditet. 
Den här uppföljande studien syftade således till att söka utröna vilka kvinnor som återgick till 
samma vikt som före graviditeten, vilka som ökade och vilka som minskade i vikt efter 
graviditeten och vad som var karaktäristiskt för de olika utfallen. Förhoppningen var att 
resultaten framöver skulle kunna bidra till förutse vilka kvinnor som skulle få vilket utfall. 
Föreslagna metoder för viktnedgång brukar vara kostrestriktioner och fysisk aktivitet, varför 
vi även tagit hänsyn till detta i denna studie. Vår primära frågeställning var dock vilka nivåer 
deras hungerstimulerande- och hungerdämpande hormoner låg på nu, hur de utvecklats sedan 
kvinnorna deltog i den föregående studien vid deras kejsarsnitt, samt hur detta hängde 
samman med deras viktutveckling och kroppsammansättning efter graviditeten. 
Det togs därför blod och ryggmärgsvätska, och därefter vägdes, mättes och genomfördes en 
kroppssammansättningsmätning på kvinnorna. Sedan indelades de i tre grupper utifrån hur 
deras BMI utvecklats över graviditeten och i efterförloppet. Det blev en Uppgångs-, en Stabil- 
och en Nedgångsgrupp.  
Våra primära resultat avseende dessa grupper var att den Stabila gruppen var den som hade 
lägst BMI, vilket var överraskande. Denna grupp låg också kvar på höga nivåer av AgRP i 
blodet. Lågt BMI korrelerade med ökade nivåer av s-AgRP och ökad leptintransport till 
hjärnan. Uppgångsgruppen visade sig ha sänkt sina s-AgRP-nivåer mest. Dessutom hade de 
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ökat koncentrationen av insulin i CNS mest, och hade även högst perifer insulinresistens av 
grupperna, vilka båda är bidragande faktorer till det metabola syndromet som sammanhänger 
med högre BMI. För första gången på människor, hittade vi också samband mellan fettintaget 
och AgRP i CNS, vilket föranleder misstankar om att kostsammansättningen kan påverka 
aptiten i högre grad än vad som tidigare trotts. Man kunde inte se någon reversering efter 
genomgången graviditet avseende den mättade leptintransporten till hjärnan, vilket talar för 
att denna transport snarare beror på BMI än graviditet.  
Den enda livsstilskomponenten som kunde kopplas till BMI var fysisk aktivitet på fritiden. 
Signifikant för ett stabilt och lågt BMI verkade således generellt vara höga nivåer av 
hungerstimulerande hormonet AgRP i serum och en hög leptintransport till hjärnan, i 
kombination med träning. 
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13. Appendeces 
Appendix 1. Gynoid and android fat distribution 
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Appendix 2. BMI and background characteristics in earlier BMI groups; normal weight (NW), 
over weight (OW) and obese (OB) 
 NW 
(n) 
OW 
(n) 
OB 
(n) 
P 
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Pre-pregnancy  BMI (kg/m2) 
22.8 (18.0 – 24.8) 
(10) 
26.9 (26.3 – 29.7) 
(8) 
30.4 (30.0 – 34.0) 
(7) 
<0.001 
a. <0.001 
b. 0.001 
c. 0.001 
Gestational weight gain (kg) 
14.5 (8.0 – 18.0) 
(10) 
12.0 (9.0 – 24.0) 
(8) 
11.1 (-2.0 – 27.0) 
(7) 
0.412 
a. 0.326 
b. 0.239 
c. 0.642 
BMI at follow up (kg/m2) 
23.3 (18.4 – 30.6) 
(10) 
28.2 (26.2 – 32.6) 
(8) 
31.5 (26.9 – 37.0) 
(7) 
0.002 
a. 0.004 
b. 0.003 
c. 0.298 
Weight change post-partum 
(kg) 
0.5 (-4.9 – 17.3) 
(10) 
4.1 (-6.0 – 13.6) 
(8) 
-0.1 (-8.8 – 13.9) 
(7) 
0.327 
a. 0.424 
b. 0.354 
c. 0.165 
BMI change from pre-
pregnancy to follow up (kg/m2) 
0.2 (-1.6 – 6.7) 
(10) 
1.5 (-1.9 – 4.7) 
(8) 
0.0 (-3.2 – 4.6) 
(7) 
0.309 
a. 0.450 
b. 0.379 
c. 0.132 
Age (years) 
40.6 (29.6 – 46.7) 
(10) 
40.0 (31.6 – 45.0) 
(8) 
41.3 (27.4 – 43.2) 
(7) 
0.881 
a. 0.593 
b. 0.884 
c. 0.817 
Parity (n) 
2 (2 – 3) 
(10) 
2 (2 – 2) 
(8) 
2 (1 – 3) 
(7) 
0.297 
a. 0.593 
b. 0.592 
c. 0.579 
Time since last pregnancy 
(years) 
6 (4 – 6) 
(10) 
5 (2 – 6) 
8 
4 (3 – 6) 
(7) 
0.102 
a. 0.163 
b. 0.033 
c. 0.527 
HOMA-IR during pregnancy 
0.9 (0.2 – 3.4) 
(10) 
1.3 (0.1 – 1.7) 
(8) 
1.1 (0.4 – 4.6) 
(7) 
0.834 
a. 0.722 
b. 0.558 
c. 0.817 
HOMA-IR at follow up 
1.1 (0.4 – 2.3) 
(9) 
1.0 (0.4 – 2.8) 
(8) 
1.7 (0.8 – 2.8) 
(7) 
0.217 
a. 0.847 
b. 0.101 
c. 0.165 
Values are medians, with minimum and maximum values within parenthesis. P-values based on 
Kruskall Wallis. Significance at the <0.005 level. 
a. Whitney U comparison between NW – OW 
b. Whitney U comparison between NW – OB  
c. Whitney U comparison between OW – OB  
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